Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Statistical Significance01:50

Statistical Significance

22.2K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
22.2K
Probability in Statistics01:14

Probability in Statistics

23.5K
Probability is the likelihood of an event occurring. The term event is defined as a collection of results of a procedure. An event is a simple event when an outcome cannot be divided into simpler parts.
An example of a simple event is a coin toss. The result of a coin toss is either a head or a tail. Here, head and tail are two simple events. These two simple events make up the sample space. Further, the probability of an event occurring falls within the range of 0 to 1. The probability of an...
23.5K
Design Consideration01:22

Design Consideration

586
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
586
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Household costs and health-related quality of life of childhood multidrug-resistant TB in Western Cape, South Africa.

IJTLD open·2026
Same author

High prevalence of TB in children less than 5 years old hospitalised with severe acute malnutrition.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle.

IJTLD open·2025
Same author

Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries.

IJTLD open·2025
Same author

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries.

IJTLD open·2025
Same author

Adolescents and young adults with TB in a low-incidence setting.

IJTLD open·2025

Related Experiment Video

Updated: Feb 11, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K

Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trials.

S Kim1, J A Seddon2, A J Garcia-Prats3

  • 1Frontier Science Foundation, Brookline, Massachusetts, USA.

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|April 19, 2018
PubMed
Summary

New oral drug regimens for pediatric multidrug-resistant tuberculosis (TB) offer shorter, safer treatment. Demonstrating non-inferiority is key, with careful trial design ensuring accurate results for this critical pediatric infectious disease.

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.1K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K

Related Experiment Videos

Last Updated: Feb 11, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.1K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K

Area of Science:

  • Pediatric infectious diseases
  • Clinical trial design
  • Tuberculosis research

Background:

  • Current multidrug-resistant tuberculosis (TB) treatments for children are lengthy and often involve injections.
  • Newly licensed or repurposed drugs offer potential for shorter, all-oral regimens in pediatric TB.
  • All-oral regimens may improve patient acceptability and safety profiles compared to existing treatments.

Purpose of the Study:

  • To outline considerations for designing clinical trials evaluating new regimens for pediatric multidrug-resistant TB.
  • To discuss strategies for demonstrating non-inferiority of novel TB treatment regimens in children.
  • To highlight the importance of robust trial methodologies for pediatric TB drug development.

Main Methods:

  • Discusses the need for appropriate non-inferiority margins and safeguarding study assay sensitivity.
  • Suggests that multi-arm, multistage designs may not be suitable due to a lack of sensitive intermediate outcomes.
  • Recommends using covariates for stratification and subgroup analysis, and enriching samples for confirmed TB cases.

Main Results:

  • Fixed timepoint primary outcomes are proposed despite variations in post-treatment duration.
  • Blinding should be maintained for independent endpoint review groups and personnel, even if not possible for site staff and patients.
  • Emphasizes the critical need for tight control of Type I and family-wise error rates in pediatric TB trials.

Conclusions:

  • Careful consideration of trial design elements is crucial for evaluating new multidrug-resistant TB treatments in children.
  • Demonstrating non-inferiority with novel oral regimens is a viable and potentially more acceptable approach.
  • Robust statistical methods and blinding strategies are essential for reliable results in pediatric TB clinical research.